Dyne Therapeutics Stock Target Price and Analyst Consensus

DYN Stock  USD 30.61  0.52  1.67%   
The current analyst and expert consensus on Dyne Therapeutics is Strong Buy, with 6 strong buy opinions. The current projected Dyne Therapeutics target price consensus is 29.50 with 10 analyst opinions. Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.
The most common way Dyne Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Dyne Therapeutics executives and customers to further validate their buy or sell advice. Dyne Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Dyne Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.8815.
Lowest Forecast
26.85
Highest Forecast
32.75
Target Price
29.5
As of the 29th of November 2024, Net Profit Margin is likely to grow to 0.18, though Gross Profit is likely to grow to (2.3 M). As of the 29th of November 2024, Property Plant Equipment is likely to grow to about 46.4 M, while Total Assets are likely to drop about 156.8 M.
  
It's important to approach Dyne Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Dyne Therapeutics price targets

Dyne Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Dyne Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Dyne Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Dyne Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Dyne Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Dyne Therapeutics is a key component of Dyne Therapeutics valuation and have some predictive power on the future returns of a Dyne Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
27.2631.1735.08
Details
Intrinsic
Valuation
LowRealHigh
26.0829.9933.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.95-0.87-0.79
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Social Domain Idea
Social Domain
Invested few shares
When determining whether Dyne Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dyne Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dyne Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dyne Therapeutics Stock:
Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.